Medical News

RSS

Neurodegenerative disorders are the second-leading cause of early-onset dementia, says report

Neurodegenerative disorders called frontotemporal dementias (FTD) are the second-leading cause of early-onset dementia in persons under age 65 and can emerge sometimes as early as age 20.

21 Sep 2009

U.N. report calls for $1.48B to help developing nations cope with H1N1

The U.N. this week will request that wealthy nations and development banks donate $1.48 billion to help developing countries fight H1N1 (swine flu), Bloomberg reports. "Most of the money is needed for vaccines and drugs … to help the least-developed nations cope with the influenza pandemic, according to a U.N. report obtained" Monday by the news service.

21 Sep 2009

Full Senate Finance Committee to take up health reform

The full Senate Finance Committee takes up health care legislation this week and there are already a slew of amendments that would significantly alter the proposal from the chairman, Sen. Max Baucus, D-Mont.

21 Sep 2009

Many Australians at risk of having a heart attack are not receiving the best possible care: Study

The research suggests that GPs are still managing individual risk factors such as blood pressure and cholesterol in isolation of one another, and are not adopting recommendations to treat a patient's overall or absolute risk. Absolute risk management is based on the principle that the major risk factors for cardiovascular disease act together. By taking this approach treatment can be targeted to those most likely to benefit.

21 Sep 2009

Confusing insurance jargon prompts call for reform

Kaiser Health News, in collaboration with the Los Angeles Times, reports on the challenges consumers confront in trying to understand insurance industry jargon. "Insurance industry critics say some insurers intentionally make their policies and procedures confusing, and some policy experts believe Congress should require standardized plan information as part of any overhaul of the health system" (Meyer, 9/21).

21 Sep 2009

Also in Global Health news: HIV/aids in Zambia; Ugandan medical workers; Obama administration officials' Q&A, speech; South African health care reform efforts; texting to combat drug shortages in Africa

The Post of Zambia examines the findings of a recent report revealing "the devastating effects" the HIV/AIDS epidemic in Zambia is having on the country's ability to meet the U.N. Millennium Development Goals. The article also looks at the relationship between HIV/AIDS and nutrition, maternal health and education (Chackwe, 9/21).

21 Sep 2009

Today's selection of opinions and editorials

Obama's Nontax Tax Wall Street Journal It turns out the President thinks a health-care tax is not a tax if he thinks the tax is for your own good (9/21).

21 Sep 2009

Medicare round up: News coverage of cost issues and leadership gap

"The national average for Medicare spending on such patients was $46,412, including outpatient care," the Times reports. "But in Los Angeles County, the average cost was nearly double that, $84,179, according to a Los Angeles Times review of Dartmouth data. In seeking to explain why, some researchers have concluded that doctors in areas such as Los Angeles, with more hospitals and other resources, are more likely to have patients admitted, order tests and schedule visits, largely because they can."

21 Sep 2009

Vitae Pharmaceuticals initiates Phase 1 clinical trial of its novel cardiovascular agent

Vitae Pharmaceuticals, Inc., an integrated discovery and development company, today announced that it has initiated a Phase 1 clinical trial of its novel cardiovascular agent, VTP-27999.

21 Sep 2009

Manhattan Scientifics inks exclusive licensing contract with Carpenter Technology

Manhattan Scientifics, Inc. (OTCBB: MHTX) announced the signing of a contract with Carpenter Technology Corporation (NYSE: CRS), wherein Carpenter will fully develop, manufacture and market a new class of high strength metals under an exclusive license from Manhattan Scientifics and the Los Alamos National Laboratory. The contract includes minimum annual payments to Manhattan Scientifics during a 4-year period, together with royalty payments as a percent of gross sales.

21 Sep 2009

Provectus' Phase 2 clinical trial of PV-10 for metastatic melanoma complete

Provectus Pharmaceuticals, Inc. (OTC BB: PVCT), a development-stage oncology and dermatology biopharmaceutical company, has completed the treatment portion, including all protocol-allowed retreatments of all patients, of its Phase 2 clinical trial of PV-10 for metastatic melanoma. The study involved treatment of 80 subjects with Stage III or Stage IV metastatic melanoma.

21 Sep 2009

Nasdaq issues noncompliance letter ThermoGenesis

ThermoGenesis Corp. (Nasdaq: KOOL), a leading supplier of innovative products for processing and storing adult stem cells, said today it had received a letter dated September 16, 2009, indicating the Company had become non-compliant with the Nasdaq Capital Markets' minimum bid pricing requirement under rule 5550(a)(2) as the Company's closing bid price for the past 30 days had failed to meet the minimum bid of $1.00 per share.

21 Sep 2009

New study reveals that large abdominal fat cells contribute to type 2 diabetes in women

Middle-aged women with large abdominal fat cells have a higher risk of developing type 2 diabetes later in life compared to women with smaller fat cells. Waist circumference divided by body height can also be used to determine which women are at risk. This is shown in a new study from the Sahlgrenska Academy at the University of Gothenburg, Sweden.

21 Sep 2009

MDC scientist receives 1 million euros for diabetic research

A European Research Council (ERC) Starting Grant worth more than a million euros over the next five years has been awarded to Dr. Francesca M. Spagnoli of the Max Delbr-ck Center for Molecular Medicine (MDC) Berlin-Buch, Germany.

21 Sep 2009

Mayo Clinic may prove to be a difficult model to replicate

The Mayo Clinic looms out of the prairie here like the mecca it has become, a world-renowned medical complex that is often cited by President Obama. ... Few dispute the prowess of Mayo, which brings in $9 billion in revenue a year and hosts 250 surgeries a day. But a battle is underway among health-care experts and lawmakers over whether its success can be so easily replicated.

21 Sep 2009

Inhalable H1N1 vaccine to arrive in U.S. first week of October, CDC says

The Centers for Disease Control and Prevention on Friday announced it anticipates 3.4 million doses of inhalable H1N1 vaccines will be available by the first week of October - the initial influx of 195 million doses purchased by the U.S. government, CNN reports. The vaccine is approved for healthy people between the ages of two and 49, but not for pregnant women (9/18).

21 Sep 2009

Enzo Biochem and NEI join to conduct a human clinical trial of Enzo’s chronic autoimmune uveitis therapeutic

Enzo Biochem, Inc. (NYSE: ENZ), announced today that it had entered into a Cooperative Research and Development Agreement (CRADA) with the National Eye Institute, part of the National Institute of Health, to conduct a human clinical trial of Optiquel™, Enzo’s oral, proprietary therapeutic for chronic autoimmune uveitis.

21 Sep 2009

Clinical trial results of topical INCB18424 inhibitor announced by Incyte Corporation

Incyte Corporation (Nasdaq:INCY) announced positive clinical trial results for a topical formulation of its lead janus kinase (JAK) inhibitor, INCB18424, in psoriasis.

21 Sep 2009

Malpractice reform in spotlight, earns mixed reviews

"Republican lawmakers have long touted federal tort reform as way to bring down health-care costs. Democrats are coming around to the same position in response to what they've heard from constituents. ... President Barack Obama recently raised the issue as an olive branch to Republicans, directing the Department of Health and Human Services to spend $25 million to help states and health-care systems try alternative methods of resolving malpractice allegations."

21 Sep 2009

Navicure adds two Minnesota-based organizations to its client roster

Navicure, a leading Internet-based medical claims clearinghouse for physician practices, today announced the addition of two Minnesota-based organizations to its client roster. Heartland Orthopedic Specialists and Fond du Lac Human Services both selected Navicure’s award-winning account receivables management solutions to improve claims management and increase profitability.

21 Sep 2009

Medical News

Neurodegenerative disorders are the second-leading cause of early-onset dementia, says report

U.N. report calls for $1.48B to help developing nations cope with H1N1

Full Senate Finance Committee to take up health reform

Many Australians at risk of having a heart attack are not receiving the best possible care: Study

Confusing insurance jargon prompts call for reform

Also in Global Health news: HIV/aids in Zambia; Ugandan medical workers; Obama administration officials' Q&A, speech; South African health care reform efforts; texting to combat drug shortages in Africa

Today's selection of opinions and editorials

Medicare round up: News coverage of cost issues and leadership gap

Vitae Pharmaceuticals initiates Phase 1 clinical trial of its novel cardiovascular agent

Manhattan Scientifics inks exclusive licensing contract with Carpenter Technology

Provectus' Phase 2 clinical trial of PV-10 for metastatic melanoma complete

Nasdaq issues noncompliance letter ThermoGenesis

New study reveals that large abdominal fat cells contribute to type 2 diabetes in women

MDC scientist receives 1 million euros for diabetic research

Mayo Clinic may prove to be a difficult model to replicate

Inhalable H1N1 vaccine to arrive in U.S. first week of October, CDC says

Enzo Biochem and NEI join to conduct a human clinical trial of Enzo’s chronic autoimmune uveitis therapeutic

Clinical trial results of topical INCB18424 inhibitor announced by Incyte Corporation

Malpractice reform in spotlight, earns mixed reviews

Navicure adds two Minnesota-based organizations to its client roster

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Latest News